Track safety after COVID-19 vaccination in adults
Part of Infections, Lungs & breathing clinical trials.
This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must be able to give informed consent on your own.
- You must be a healthcare worker (HCW), an office/outreach worker (OA), or a student/trainee (ST).
- You must have already received a COVID-19 vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a COVID-19 vaccine in healthy adults to see how well it works. It may be an option if you are not at higher risk for severe COVID-19 and have not had COVID-19 in the past 6 months.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This study looks at genetic information to better understand why some people develop serious side effects after a COVID-19 vaccine, such as GBS, blood clotting with low platelets (VITT/TTS), or heart inflammation (myocarditis/pericarditis). Your information may help researchers learn who is at higher risk and improve future safety.
This study tests an experimental COVID-19 vaccine to see if it is safe and how well it works against current variants. It is for healthy adults who have had a previous COVID-19 vaccine or infection.
This Phase 3 trial tests a booster vaccine made from a three-part COVID-19 protein (aimed at XBB, BA.5, and Delta) to see how well it works and is tolerated. It may help adults who are due for a COVID-19 booster, including people with certain health conditions, depending on screening results.
This study looks at how antibodies (proteins that fight disease) change over time after getting a recommended vaccine. It aims to learn more about vaccine response in real-life situations.
Hear when a new Adverse Reaction to Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.